You are here » Home » Companies » Company Overview » Celestial Biolabs Ltd

Celestial Biolabs Ltd.

BSE: 532871 Sector: Health care
NSE: CELESTIAL ISIN Code: INE221I01017
BSE LIVE 15:40 | 09 Dec 20.60 -0.20
(-0.96%)
OPEN

19.40

HIGH

21.00

LOW

19.40

NSE LIVE 15:31 | 09 Dec 20.75 0.20
(0.97%)
OPEN

20.45

HIGH

20.85

LOW

20.45

OPEN 19.40
PREVIOUS CLOSE 20.80
VOLUME 3624
52-Week high 42.45
52-Week low 18.15
P/E 23.95
Mkt Cap.(Rs cr) 42.21
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 19.40
CLOSE 20.80
VOLUME 3624
52-Week high 42.45
52-Week low 18.15
P/E 23.95
Mkt Cap.(Rs cr) 42.21
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Celestial Biolabs Ltd. (CELESTIAL) - Chairman Speech

Company chairman speech

CHAIRMAN’S ADDRESS

Dear Share owners

Innovation backed by technology always plays an important role in biopharmaceuticals.Initiative towards Biopharma product development that is process driven time taking andexpensive is continuing with available resources. New and Innovative products shall alwayscreate demand and your company shall be benefitted. Ultimately our R&D initiativeshave given us two research products like Cadalmin and Biovita. 4 New molecules in peptideand 5 products in Enzymes are in advance stage of development. Anti diabetes product fullyvalidated and clinically tested is ready to be launched shortly At this stage Now wehave the range of products and making suitable promotional strategy to create consumerinterest and demand.

Performance

Herbal and Enzyme formulations can also be marketed worldwide by using online platformalong with off line present marketing activities We are moving in synergy by improvingour supply chain and also introducing new control measures. We have already startedadvertising our Lead research product called Cadalmin Our effort is continued toestablish OTC market for all our products.

Industry

The future outlook of Biopharmaceutical Industry is very good but we are passingthrough a difficult phase Pharma industry shall be able to keep the pace with the goodquality products as there is always demand for such quality pharma products. Our most ofthe products are very effective and we are making every effort to meet the demand. We aredeveloping effective supply chain management by introducing new CSA and stockiest atdifferent places. We are also introducing incentive scheme to stockiest sales person inorder to increase the volume of sales The biopharmaceutical market is highly competitive.In order to have a competitive edge our facility at Biotech park is an integratedfacility clubbed with extremely good facility of R&D where product development ofinnovative project shall be the key factor. We will continue to pursue our R&Dinitiative in peptide Enzymes and protein and proceed with manufacturing of theseproducts at new facility. Project at SEZ Biotech park. This will provide us anopportunity to market our products in Domestic and overseas market.

Strategy

Shift shall be towards brand building and advertising to handle OTC marketing We areable to build better volume by Strengthening the manufacturing marketing anddistribution..We are in the process of meeting WHO norms and stamping on the premierproducts shall provide us an opportunity to market our products in African and south EastAsian countries. Reaching everywhere through C&F and distributors is an difficultproposition and online sales will take us at every corner of India. Feed supplement tocattle’s poultry and fisheries is an major task to us and celestial is continuouslytrying to improve the reach and increase the range of feed supplements in order to spreadthe sale of feed supplements across India.

Human Resource

Effective and Quality manpower and their retention is always an challenging task andaddressing this task carefully shall increase the productivity. We have taken very carefulsteps to retain only quality dedicated and efficient staff. Training courses and sendingthem to various seminars and symposium shall also be our priority and thus we will ensureprofessional skill development. We have taken a Person with Company secretary andchartered accountancy qualification and also are in the process of recruiting Businessdevelopment and Reserch and developmental professionals

Collaboration

Collaborative research is essential for a company like us so that we can always fulfillour research objective most economically and effectively. We are also developingcollaborations with CSIR and ICAR and ICMR institutions to develop the Biotech products.Collaborative research projects with these premier research organization shall provide acompetitive edge and also increase our learning graph having association with veryexperienced Research scientists of these prominent institutions.. We are also installingsoftware at each C&F in all the states to make our monitoring and control moreeffective.ly We are making every effort to complete the remaining work at city and Biotechpark facility so that production supply chain can be improved in order to increase thebusiness volume. CMFRI Kochin association has given us Cadalmin a great product. Cadalminefficacy is so high that people suffering from arthritis are getting tremendous relief.Further we are moving to launch a much needed research product to treat diabetes.

Value to the shareholders

Shareholders are very important to us. We always keep shares holders interest onpriority and would like to ensure all our shares holders shall be benefitted immensely. .Increasing the investor wealth is our top priority and we will make rapid progress towardsachieving our objective once our capital project is completed. We always address anycomplaint by shareholders very promptly

Corporate Social responsibility

We are providing medicines on avery concessional rate to under privileged and handicappeople who can not afford to buy the expensive medicines. This distribution is being donein villages through AWAKE RESEARCH and SERVICE FOUNDATION a voluntary and socialorganization. We are also making effort to buy herbal raw material from farmers drivensource directly by giving value to farmers and also ensuring good quality of raw material.There is very good response from farmers to work on contract farming to grow medicinalplants and shall be moving shortly to have such agreement with farmers cooperative society

Acknowledgment

We thank all our shareholders stake holders staff and business associates for theircontinued support and look forward to your valuable advice to achieve our objective.

Dr A.N. Singh

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard